Apart from the inhibition of HSP70 the tumor-specific membrane expression of HSP70 can serve as a tumor target for anti-tumor immune responses [133,134] or for the specific nanoparticle-based therapies [135,136]. The gene discussed is HSPA1A; the disease is neoplasm.